UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Risk factors and management of pasireotide-associated hyperglycemia in acromegaly

Endocrine Connections, 2020-12, Vol.9 (12), p.1178-1190

2020

Volltextzugriff (PDF)

Abstract #1040637: Effect of Osilodrostat on Clinical signs, Physical Features and Health-related Quality of Life (HRQoL) by Degree of mUFC Control in Patients with Cushing’s Disease (CD): Results from the LINC3 Study

Endocrine practice, 2021-06, Vol.27 (6), p.S130-S131

2021

Volltextzugriff (PDF)

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

The lancet. Diabetes & endocrinology, 2014-11, Vol.2 (11), p.875-884

2014

Volltextzugriff (PDF)

Evaluation of an individualized education program in pituitary diseases: a pilot study

European journal of endocrinology, 2020-12, Vol.183 (6), p.551

2020

Volltextzugriff (PDF)

Impact of Cushing's syndrome on fertility and pregnancy L'impact du syndrome de Cushing sur la fertilite et la grossesse

Annales d'endocrinologie, 2022, Vol.83 (3, SI), p.188-190

2022

Volltextzugriff (PDF)

MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma

European journal of endocrinology, 2016-01, Vol.174 (1), p.R9

2016

Volltextzugriff (PDF)

Active cushing syndrome patients have increased ectopic fat deposition and bone marrow fat content compared to cured patients and healthy subjects: a pilot 1H-MRS study

European journal of endocrinology, 2018-11, Vol.179 (5), p.307

2018

Volltextzugriff (PDF)

A conservative management is preferable in milder forms of pituitary tumor apoplexy

Journal of endocrinological investigation, 2011-07, Vol.34 (7), p.502-509

2011

Volltextzugriff (PDF)

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

Endocrine-related cancer, 2009-09, Vol.16 (3), p.1029-1043

2009

Volltextzugriff (PDF)

Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database

Endocrine, 2020-10, Vol.70 (1), p.134-142

2020

Volltextzugriff (PDF)

Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease

Genes & development, 2006-10, Vol.20 (20), p.2871-2886

2006

Volltextzugriff (PDF)

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues

European journal of endocrinology, 2017-04, Vol.176 (4), p.421

2017

Volltextzugriff (PDF)

Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families

The journal of clinical endocrinology and metabolism, 2007-05, Vol.92 (5), p.1891-1896

2007

Volltextzugriff (PDF)

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients

Endocrine-related cancer, 2015-10, Vol.22 (5), p.745-757

2015

Volltextzugriff (PDF)

Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures

Endocrine-related cancer, 2014-10, Vol.21 (5), p.691-704

2014

Volltextzugriff (PDF)

GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency

Hormone and metabolic research, 2016-06, Vol.48 (6), p.389

2016

Volltextzugriff (PDF)

Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

The journal of clinical endocrinology and metabolism, 2020-09, Vol.105 (9), p.2964-2974

2020

Volltextzugriff (PDF)

High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery

European journal of endocrinology, 2024-01, Vol.190 (1), p.75

2024

Volltextzugriff (PDF)

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

Endocrine-related cancer, 2016-11, Vol.23 (11), p.871-881

2016

Volltextzugriff (PDF)

Acromégalie : améliorer la prise en charge

Annales d'endocrinologie, 2019-09, Vol.80, p.S10-S18

2019

Volltextzugriff (PDF)

A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly

European journal of endocrinology, 2018-08, Vol.179 (2), p.97

2018

Volltextzugriff (PDF)

Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up

The journal of clinical endocrinology and metabolism, 2010-04, Vol.95 (4), p.1708-1716

2010

Volltextzugriff (PDF)

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN

European journal of endocrinology, 2017-05, Vol.176 (5), p.613

2017

Volltextzugriff (PDF)

Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency

Genes & development, 2003-03, Vol.17 (6), p.711-716

2003

Volltextzugriff (PDF)

Novel Mutations within the POU1F1 Gene Associated with Variable Combined Pituitary Hormone Deficiency

The journal of clinical endocrinology and metabolism, 2005-08, Vol.90 (8), p.4762-4770

2005

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(51)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(29)
Endocrinology & Metabolism
(28)
Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Female
(19)
Male
(17)
Adult
(16)
Life Sciences
(13)
Middle Aged
(13)
Acromegaly
(8)
Aged
(8)
Endocrinologie, Métabolisme & Nutrition
(8)
Endocrinology, Metabolism & Nutrition
(8)
Human Health Sciences
(8)
Sciences De La Santé Humaine
(8)
Endocrinopathies
(7)
Acromegaly - Drug Therapy
(6)
Adolescent
(6)
Clinical Study
(6)
Human Health And Pathology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk factors and management of pasireotide-associated hyperglycemia in acromegaly

Abstract #1040637: Effect of Osilodrostat on Clinical signs, Physical Features and Health-related Quality of Life (HRQoL) by Degree of mUFC Control in Patients with Cushing’s Disease (CD): Results from the LINC3 Study

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

Evaluation of an individualized education program in pituitary diseases: a pilot study

Impact of Cushing's syndrome on fertility and pregnancy L'impact du syndrome de Cushing sur la fertilite et la grossesse

MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma

Active cushing syndrome patients have increased ectopic fat deposition and bone marrow fat content compared to cured patients and healthy subjects: a pilot 1H-MRS study

A conservative management is preferable in milder forms of pituitary tumor apoplexy

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database

Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues

Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients

Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures

GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency

Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

Acromégalie : améliorer la prise en charge

A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly

Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN

Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency

Novel Mutations within the POU1F1 Gene Associated with Variable Combined Pituitary Hormone Deficiency

Suchergebnisse filtern